BD’s Liverty TIPS Stent Graft Receives CE Mark Approval in Europe

April 10, 2026—BD (Becton, Dickinson and Company) announced European CE Mark approval for the Liverty transjugular intrahepatic portosystemic shunt (TIPS) stent graft.

The company’s next-generation, adjustable-diameter device is an interventional therapy to address complex liver disease, expanding treatment options for patients with cirrhosis and complications of portal hypertension. In the United States, the Liverty TIPS stent graft is an investigational device limited by Federal law to investigational use only.

According to the company, the Liverty TIPS stent graft is engineered to support individualized patient management, offering a 6 to 10 mm adjustable inner diameter and a broad range of covered TIPS stent lengths. The device includes a flexible, self-expanding nitinol frame and dual-layer expanded polytetrafluoroethylene encapsulation with carbon impregnation on the inner surface. It is delivered fully constrained on a triaxial delivery system designed for placement accuracy, control, and ease of use, stated BD.

The company advised that the Liverty TIPS device was evaluated in the pivotal ARCH clinical trial. The global, prospective, multicenter, single-arm clinical study assessed the safety and effectiveness of the Liverty TIPS stent graft for the treatment of complications from portal hypertension.

Global Principal Investigator Ziv Haskal, MD, will present the ARCH data at SIR 2026, the Society of Interventional Radiology’s annual scientific meeting, noted the company.

“The Liverty TIPS stent graft represents an important advancement in how we care for patients with the serious complications of portal hypertension,” commented Dr. Haskal in BD’s press release. “Its adjustable diameter and delivery design allow physicians to better match the shunt to a patient’s unique physiology, a key consideration in safe and effective TIPS creation. The trial provides the first and only prospective data describing the results of small-diameter calibrated TIPS for treating all the major complications of portal hypertension.”